A) Cytogenetic incidence: aberrant karyotypes including normal did not differ between groups. B) Mutational findings in patient cohort comparing AML-post-MDS vs. dn-AML-MDS with significant difference regarding FLT3-ITD mutation.

 
 
  Part of: Jagurinoski M, Davidkova Y, Stojcov-Jagurinoska M, Balatzenko G, Spassov B, Guenova M (2023) Secondary acute myeloid leukemia and de novo acute myeloid leukemia with myelodysplasia-related changes - close or complete strangers? Folia Medica 65(5): 728-736. https://doi.org/10.3897/folmed.65.e98404